OraSure Technologies, Inc.
(NASDAQ : OSUR)

( )
OSUR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 15.10%24.096.3%$1328.24m
TMOThermo Fisher Scientific, Inc. -0.47%380.471.0%$566.31m
MDTMedtronic Plc -1.62%91.700.6%$553.30m
DXCMDexCom, Inc. 0.63%425.868.2%$528.90m
BDXBecton, Dickinson & Co. 0.42%251.521.0%$523.58m
ABTAbbott Laboratories -0.62%92.390.8%$512.30m
DHRDanaher Corp. -0.58%181.940.7%$455.51m
BSXBoston Scientific Corp. -2.64%34.651.0%$421.55m
QDELQuidel Corp. -4.50%224.987.7%$375.71m
ISRGIntuitive Surgical, Inc. -1.59%575.342.4%$346.29m
SYKStryker Corp. -1.91%180.381.3%$312.43m
BAXBaxter International, Inc. -2.96%85.501.8%$285.33m
ALGNAlign Technology, Inc. -2.74%274.716.4%$250.08m
EWEdwards Lifesciences Corp. -1.41%68.550.4%$207.26m
ZBHZimmer Biomet Holdings, Inc. -0.95%116.951.7%$204.71m

Company Profile

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.